The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

NCT04728516 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

2600

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Helicobacter Pylori Infection

Interventions

DRUG: Vonoprazan-based dual eradication therapy for two weeks
DRUG: amoxicillin
DRUG: Pantoprazole

Sponsor

Qilu Hospital of Shandong University